PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 107 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,469 | -29.6% | 4,292 | -18.9% | 0.00% | – |
| Q1 2023 | $13,456 | +34.2% | 5,292 | -0.3% | 0.00% | – |
| Q4 2022 | $10,030 | -22.8% | 5,308 | +10.8% | 0.00% | – |
| Q3 2022 | $13,000 | +44.4% | 4,792 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -35.7% | 4,792 | 0.0% | 0.00% | – |
| Q1 2022 | $14,000 | -39.1% | 4,792 | -9.4% | 0.00% | – |
| Q4 2021 | $23,000 | -57.4% | 5,292 | -53.2% | 0.00% | – |
| Q3 2021 | $54,000 | -41.9% | 11,310 | -16.2% | 0.00% | – |
| Q2 2021 | $93,000 | -22.5% | 13,490 | -19.8% | 0.00% | – |
| Q1 2021 | $120,000 | +16.5% | 16,820 | +2.4% | 0.00% | – |
| Q4 2020 | $103,000 | +145.2% | 16,420 | +109.7% | 0.00% | – |
| Q3 2020 | $42,000 | +10.5% | 7,830 | +9.8% | 0.00% | – |
| Q2 2020 | $38,000 | +65.2% | 7,130 | 0.0% | 0.00% | – |
| Q1 2020 | $23,000 | – | 7,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |